Quick Answer: UK cosmetic safety report requirements should be checked for the intended market, with Great Britain and Northern Ireland considered separately. For GB, the responsible person must ensure that a product has a safety assessment before market placement. The Cosmetic Product Safety Report, or CPSR, contains supporting safety information and a qualified assessor’s evaluation. A supplier’s SDS, batch certificate or notification record does not replace that product-specific assessment.
By mooyam_admin (MOOYAM editorial team). Last reviewed: 6 October 2026. Cover: AI-generated editorial illustration.
What is a Cosmetic Product Safety Report?
A CPSR is the documented safety evaluation of a cosmetic product, built on information about its composition, characteristics, intended use and exposure. It is not simply a laboratory result or a marketing statement saying that a formula is safe. The assessment must address the actual product and the evidence supporting its use.
The OPSS statutory guidance for Great Britain explains Article 10 and Annex I of the applicable cosmetics framework. It describes a CPSR with Part A safety information and Part B assessment, signed by a qualified assessor. The safety review considers normal and reasonably foreseeable use, not just the brand’s ideal use scenario.
Does the same advice apply across the whole UK?
Do not treat “UK” as a single undifferentiated compliance route. This guide’s main preparation checklist concerns GB. For Northern Ireland, consult the separate official NI guidance, which explains the framework applying there and provisions for qualifying NI goods supplied to GB.
Where a report already exists for another market, ask the relevant responsible person and assessor to perform a gap review. Do not assume that its title guarantees acceptance, or that every underlying study must automatically be repeated. Suitability depends on the product, applicable requirements and evidence, including any subsequent changes.
What goes into Part A?
Part A assembles the evidence needed for an informed evaluation. The GB guidance identifies composition, physical and chemical properties, stability, microbiological quality, impurities, packaging, use, exposure, toxicological information and available undesirable-effect information. It is the foundation for the assessor’s reasoning, not an exercise in collecting unrelated certificates.
| Information group | What to prepare for review | Common gap |
|---|---|---|
| Product identity and composition | Controlled formula, ingredient identities and relevant specifications | A marketing INCI list without sufficient quantitative information |
| Physical characteristics and stability | Relevant product data and study details | Results that do not identify the tested version |
| Microbiological information | Applicable quality and preservation evidence | Assuming one result addresses every microbiological question |
| Impurities and packaging | Relevant material information and product-container evidence | Changing the container without reviewing its implications |
| Use and exposure | Application area, users, directions and foreseeable use | Evaluating a rinse-off use while marketing a leave-on use |
| Safety history | Available undesirable-effect and other relevant information | Keeping new complaint information outside the review process |
This table is a preparation aid, not a universal laboratory test order. Ask the assessor what evidence is appropriate and why. Product characteristics and exposure can change the evaluation; an identical checklist may not be suitable for every cosmetic category.
What does Part B establish?
Part B sets out the assessment conclusion, necessary warnings or instructions, and the reasoning behind that conclusion. The GB guidance also calls for the assessor’s identity, qualifications, signature and date. The conclusion should be supported by the information evaluated, with restrictions made clear where relevant.
For a brand, the practical task is to connect that conclusion to commercialization. If the assessment depends on a particular use instruction or warning, make sure the final artwork reflects it. If the report lists a specific formula or packaging configuration, confirm that production has not moved to a different version.
Do not describe a report as “passed by the government” merely because it contains a favorable conclusion. A qualified assessor’s evaluation, government notification and regulatory enforcement are different functions.
Who prepares and controls the report?
The responsible person must ensure the assessment is completed. The qualified assessor performs the specialist evaluation. The GB guidance describes relevant formal qualifications in pharmacy, toxicology, medicine or a similar discipline, or an appropriately recognized equivalent course. A job title such as “consultant” alone does not establish the required qualifications.
| Party | Practical contribution | Release check |
|---|---|---|
| Manufacturer | Agreed formula, raw-material, manufacturing and testing information | Documents match the product supplied |
| Brand owner | Target users, claims, directions, packaging decisions and market plan | Commercial presentation matches the assessed use |
| Qualified assessor | Evidence evaluation, conclusion, reasoning and required restrictions | Assessment is properly identified, signed and current |
| Responsible person | Ensure assessment and wider compliance obligations are fulfilled | Required evidence remains accessible and controlled |
This coordination model does not replace statutory duties or the actual service agreement. For the appointment question, read UK responsible person requirements. Resolve access to confidential formula information before commissioning the evaluation.
Is a CPSR the same as the product information file?
No. The CPSR is part of the wider product information file, or PIF. The GB guidance also identifies product description, manufacturing and GMP information, evidence of claimed effects where relevant, and animal-testing information among the PIF elements. A safety report alone is therefore not the complete dossier.
Keep a document index that connects the marketed product to its current report and supporting records. As a practical control, identify the document owner, version, date, product code and review status. A well-organized index helps reviewers find evidence; it does not compensate for missing evidence.
Does SCPN submission replace a safety assessment?
No. OPSS notification guidance explains the information submitted through SCPN. Submission is not a substitute for the safety and documentation work required before placing a cosmetic on the market. Do not use a portal reference number as proof that all evidence has been reviewed.
For overall sequencing, see the UK market-entry guide. Run the technical assessment, artwork review and notification preparation as connected tasks, with a clear release decision at the end.
When should a report be reviewed?
The GB guidance calls for review and revision, particularly when new information could alter the safety conclusion. There is no sensible basis for treating a report as permanently valid regardless of product changes. Equally, do not invent a universal annual expiry date where none has been established for the specific situation.
- Inform the reviewer before implementing material formula changes.
- Review packaging changes that could affect the assessed product.
- Check new intended users, application areas or directions.
- Escalate relevant new safety information and complaints.
- Consider changes in applicable requirements and new technical data.
These are change-control prompts. The assessor and responsible person should determine the necessary response. Products for children under three and products intended exclusively for external intimate hygiene require the specific safety consideration described in the GB guidance.
How can brands avoid delays?
- Define the final product, intended users and destination before requesting a quote.
- Collect a document index and identify missing technical inputs.
- Agree confidential information access among the manufacturer and reviewers.
- Ask the assessor for a reasoned gap list rather than guessing tests.
- Complete required work and resolve inconsistencies.
- Reconcile the report with production specifications and final artwork.
- Store the approved version and set a change-notification process.
Timelines depend on evidence readiness, testing needs, reviewer availability and product complexity. Request a product-specific schedule. This guide does not invent a standard turnaround or promise that a safety report can be completed before required evidence exists.
Frequently asked questions
Can an SDS replace the CPSR?
No. An SDS has a different purpose and does not replace the product-specific cosmetic safety assessment.
Does a COA prove the product is safe for every intended use?
No. A COA reports specified quality information; the broader assessment must address the product, exposure and available evidence.
Can I write the assessment myself?
Only a person meeting the applicable assessor requirements should perform the specialist assessment. Being the brand owner does not by itself establish those qualifications.
Must every cosmetic undergo the same tests?
Do not assume a universal test package. Have the qualified assessor identify and justify the evidence needed for the actual product.
Can I change the fragrance after the report is signed?
Do not assume the existing conclusion covers the change. Supply the revised information for review before relying on the original assessment.
Prepare manufacturing evidence early
MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. Discuss your intended product and assessor’s evidence requirements through our OEM/ODM manufacturing service or contact MOOYAM. The agreed manufacturing documentation supports, but does not replace, the qualified safety assessment.
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or qualified compliance professional before placing cosmetic products on the market.